President Donald Trump signed an executive order aimed at accelerating research into psychedelic drugs, directing federal agencies to reduce regulatory barriers and improve data sharing between the Food and Drug Administration and the Department of Veterans Affairs. The order facilitates faster rescheduling of any psychedelic substance that gains FDA approval, though it does not immediately reclassify drugs or expand legal therapeutic use. Currently, substances like LSD and psilocybin are classified as having high potential for abuse and no accepted medical use, severely restricting scientific study. Trump cited ibogaine during the White House signing, claiming patients experienced an 80 to 90 percent reduction in depression and anxiety symptoms within one month, adding, "Can I have some, please?" as a joke. The FDA remains responsible for determining medical efficacy, and only upon such approval could clinical access be expanded. Research has been limited due to existing drug classifications, despite growing interest in psychedelics for treating severe anxiety, depression, and post-traumatic stress, particularly among veterans. The Department of Veterans Affairs reported 6,398 veteran suicides in 2023. While potential mental health benefits are being explored, risks remain; ibogaine, for example, is associated with possible heart damage.

💡 NaijaBuzz Take

Trump highlights ibogaine's potential to reduce veterans' depression by 80 to 90 percent while the same level of urgency is not applied to expanding mental health services for Nigerian veterans of regional conflicts. With 6,398 American veterans dying by suicide in 2023, the scale of the crisis is laid bare, yet no comparable data or support system exists for Nigerian ex-servicemen facing similar trauma. The irony lies in promoting a drug still deemed unsafe for broad use as a solution, while proven mental health infrastructure remains underfunded. For Nigerian veterans, even access to a crisis hotline like the US 988 service is nonexistent.

💡 NaijaBuzz is an AI-assisted news aggregator. This content is curated from third-party sources — NaijaBuzz is not the original publisher and is not responsible for the accuracy of source reporting. The NaijaBuzz Take is AI-assisted editorial opinion only, not established fact. All persons mentioned are presumed innocent until proven guilty by a court of competent jurisdiction. NaijaBuzz does not endorse the views expressed in source articles.